!!Thomas Eschenhagen - Curriculum Vitae

*1978-1986 Hannover Medical School (MHH), degree physician\\
*1988 Medical thesis (PhD equivalent) Hannover Medical School\\
*1992 Molecular Biology Diploma, University of Hamburg\\
*1994 Habilitation, University of Hamburg\\
*1995 Approval as specialist in Pharmacology and Toxicology, Physician´s Board Hamburg\\
*1997 Approval as specialist in Clinical Pharmacology, Physician´s Board Hamburg\\
*1994-1998 Heisenberg grant DFG, Visiting scientist in Washington University, St. Louis, USA, Stanford Research Center, Menlo Park, USA, National Institute of Ageing, NIH, Baltimore, USA, Universite Paris 11, INSERM U-446, Chatenay Malabry, France
\\
__Research support and activities in research consortia (selection)__
\\
*2000-2002 Coordinator and speaker, DFG Graduate School 750, University of Erlangen "Vascular damage in kidney and heart"\\
*2005-2011 Coordinator and speaker, DFG Research Group FOR 604 "Signaling pathways in the healthy and diseased heart", University of Hamburg\\
*2004-2009 Core member Fondation LeDucq Transatlantic Networks of Excellence "Cardiac Progenitors Transatlantic Alliance" (ccordinators K. Schwartz, K. Chien) \\
*2015-2019 German Centre for Cardiovascular Research DZHK, Partner site Hamburg/Kiel/Lübeck, PI Eschenhagen\\
*2013-2017 British Heart Foundation (coordinator S. Harding, ICL, UK) Regenerative Medicine Centres, PI Eschenhagen\\
*2013-2019 ERC AG "IndivuHeart - individualized risk assessment with hiPSC-derived engineered heart tissue"\\
*2014-2017 British National Centre for the Reduction of Animal Experiments (NCR) CRACK-IT Challenges "Engineered 2D & 3D hiPSC-CM platforms to detect cardiovascular safety liabilities (coordinator C. Denning, Nottingham, UK), PI Eschenhagen\\
*2016-2018 EU Horizon 2020 ITN "Atrial Fibrillation (coordinator T. Jespersen, Kopenhagen, DK), PI Christ and Eschenhagen\\
*2017-2020 ERA-CVD "Variation" (coordinator Y. Pinto, Amsterdam, NL), PI Eschenhagen
\\
__Activities on knowledge management__
\\
*Board member German Heart Association (2003), German Association for Chronic Diseases (2005), Galenus von Pergamon *Award Committee (2012), German Physician´s Drug Commission (2008), European Society of Cardiology Heart Failure Association (2006-2012)\\
*Editorial Board membership J Mol Cell Cardiol; Bas Res Cardiol, Clin Res Cardiol, Cardiovasc Res (Associate Editor 20014-2016)\\
*Associate Editor, Circulation (since 2016)\\
*2004-2012 Member DFG Selection panel for Cardiovascular Research\\
*2012-2017 Member DFG Selection panel for Collaborative Research Centers (SFB)\\
*Reviewer for British Heart Foundation (e.g. Excellence Centres), Netherlands Academy of Science (ICIN Evaluation), Austrian Science Board, INSERM and others\\
*2004 Organizer of EU Workshop on "The Future of Young Scientists in Cardiovascular Research"\\
*Since 2006 Organizer/coorganizer of the ESC-HFA Winter Meeting on Translational Heart Failure Research)\\
*2006 Member of roadmap procedures for the NIH (stem cells) and the German Ministry of Education and Research (BMBF) and the EU\\
*2008-2012 Speaker of the Scientific Advisory Board of the Leibniz Institute of Arteriosclerosis Research (LIFA) in Münster\\
*Speaker DZHK (since 2011)\\
*2017 Coorganizer of the Annual Meeting of the ISHR European Section, Hamburg (main organizer L. Carrier)\\
*2018 Coorganizer of the Gordon Research Conference on Cardiac Regulatory Mechanisms\\
*2018 President of the Annual Meeting of the German Society for Cardiology (DGK, Mannheim)\\ \\